|
1
|
Wang LJ, He CC, Sui X, Cai MJ, Zhou CY, Ma
JL, Wu L, Wang H, Han SX and Zhu Q: MiR-21 promotes intrahepatic
cholangiocarcinoma proliferation and growth in vitro and in vivo by
targeting PTPN14 and PTEN. Oncotarget. 6:5932–5946. 2015.PubMed/NCBI
|
|
2
|
Narouie B, Ziaee SAM, Basiri A and Hashemi
M: Functional polymorphism at the miR-502-binding site in the
3′untranslated region of the SETD8 gene increased the risk of
prostate cancer in a sample of Iranian population. Gene.
626:354–357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mandujano-Tinoco EA, García-Venzor A,
Muñoz-Galindo L, Lizarraga-Sanchez F, Favela-Orozco A,
Chavez-Gutierrez E, Krötzsch E, Salgado RM, Melendez-Zajgla J and
Maldonado V: miRNA expression profile in multicellular breast
cancer spheroids. Biochim Biophys Acta. 1864:1642–1655. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma S, Umar S, Potus F, Iorga A, Wong
G, Meriwether D, Breuils-Bonnet S, Mai D, Navab K, Ross D, et al:
Apolipoprotein A-I mimetic peptide 4F rescues pulmonary
hypertension by inducing microRNA-193-3p. Circulation. 130:776–785.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cooper SJ, Zou H, Legrand SN, Marlow LA,
von Roemeling CA, Radisky DC, Wu KJ, Hempel N, Margulis V, Tun HW,
et al: Loss of type III transforming growth factor-beta receptor
expression is due to methylation silencing of the transcription
factor GATA3 in renal cell carcinoma. Oncogene. 29:2905–2915. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Finger EC, Turley RS, Dong M, How T,
Fields TA and Blobe GC: TbetaRIII suppresses non-small cell lung
cancer invasiveness and tumorigenicity. Carcinogenesis. 29:528–535.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gordon KJ, Dong M, Chislock EM, Fields TA
and Blobe GC: Loss of type III transforming growth factor beta
receptor expression increases motility and invasiveness associated
with epithelial to mesenchymal transition during pancreatic cancer
progression. Carcinogenesis. 29:252–262. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hempel N, How T, Dong M, Murphy SK, Fields
TA and Blobe GC: Loss of betaglycan expression in ovarian cancer:
Role in motility and invasion. Cancer Res. 67:5231–5238. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Turley RS, Finger EC, Hempel N, How T,
Fields TA and Blobe GC: The type III transforming growth
factor-beta receptor as a novel tumor suppressor gene in prostate
cancer. Cancer Res. 67:1090–1098. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong M, How T, Kirkbride KC, Gordon KJ,
Lee JD, Hempel N, Kelly P, Moeller BJ, Marks JR and Blobe GC: The
type III TGF-beta receptor suppresses breast cancer progression. J
Clin Invest. 117:206–217. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gatza CE, Holtzhausen A, Kirkbride KC,
Gordon KJ, Lee JD, Hempel N, Kelly P, Moeller BJ, Marks JR and
Blobe GC: Type III TGF-β receptor enhances colon cancer cell
migration and anchorage-independent growth. J Clin Invest.
117:206–217. 2007.PubMed/NCBI
|
|
12
|
Sarraj MA, Chua HK, Umbers A, Loveland KL,
Findlay JK and Stenvers KL: Differential expression of TGFBR3
(betaglycan) in mouse ovary and testis during gonadogenesis. Growth
Factors. 25:334–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mu X, Pradere JP, Affό S, Dapito DH,
Friedman R, Lefkovitch JH and Schwabe RF: Epithelial transforming
growth factor-β signaling does not contribute to liver fibrosis but
protects mice from cholangiocarcinoma. Gastroenterology.
150:720–733. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou X, Zang H and Liu H L: An excerpt of
intrahepatic cholangiocarcinoma: expert consensus statement. J Clin
Hepatol. 31:1584–1587. 2015.(In Chinese).
|
|
15
|
Deng M, Jing DD and Meng XJ: Effect of
MUC1 siRNA on drug resistance of gastric cancer cells to
trastuzumab. Asian Pac J Cancer Prev. 14:127–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He B, Lin X, Tian F, Yu W and Qiao B:
MiR-133a-3p inhibits oral squamous cell carcinoma (OSCC)
proliferation and invasion by suppressing COL1A1. J Cell Biochem.
Jun 1–2017.(Epub ahead of print).
|
|
17
|
Guro H, Kim JW, Choi Y, Cho JY, Yoon YS
and Han HS: Multidisciplinary management of intrahepatic
cholangiocarcinoma: Current approaches. Surg Oncol. 26:146–152.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jian B, Li Z, Xiao D, He G, Bai L and Yang
Q: Downregulation of microRNA-193-3p inhibits tumor proliferation
migration and chemoresistance in human gastric cancer by regulating
PTEN gene. Tumor Biol. 37:8941–8949. 2016. View Article : Google Scholar
|
|
19
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and −5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu XL, Xiao K, Xue B, Yang D, Lei Z, Shan
Y and Zhang HT: Dual role of TGFBR3 in bladder cancer. Oncol Rep.
30:1301–1308. 2013. View Article : Google Scholar : PubMed/NCBI
|
